MARIMED INC.
Close on Oct 19, 2026
- Market cap
- $22.78M
- P/E (TTM)
- –
- Dividend yield
- –
About Marimed
Medicinal Chemicals & Botanical Products, SIC 2833
MariMed Inc. is a multi-state cannabis operator engaged in the cultivation, production, and dispensing of medicinal and adult-use cannabis products. The company develops and markets proprietary brands across various consumption formats, including flower, concentrates, vape cartridges, edibles, and drink mixes. Its core operational segments comprise wholesale distribution and retail dispensary sales. In wholesale, MariMed sells manufactured branded items to licensed third-party dispensaries. In retail, it serves medical patients and recreational consumers seeking wellness, relaxation, and relief through physical dispensaries as well as home delivery services in select jurisdictions.
The company operates across multiple states, holding thirty-three cannabis licenses across six states, with vertically integrated operations established in Massachusetts, Delaware, Illinois, and Maryland. Retail dispensaries are operated under the Thrive brand name, alongside operating cultivation and production facilities in several locations, including Illinois, Maryland, and Massachusetts. MariMed is headquartered in Norwood, Massachusetts, and employs over nine hundred workers across its regional footprint.
Summary of the business section of Marimed's latest annual report, written by StockData.
Company profile
Company
- Legal name
- MARIMED INC.
- Headquarters
- Norwood, MA
- Address
- 10 Oceana Way, 2nd Floor 02062
- Phone
- (781) 277-0007
- Website
- marimedinc.com
- Employees
- 923, Dec 31, 2025
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- M&K CPAS, PLLC, The Woodlands, TX
Stock & identifiers
- Ticker
- MRMD
- Exchange
- OTC
- Shares outstanding
- 403M, Aug 10, 2026
- Public float
- $22.60M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- SEC CIK
- 1522767
- CUSIP
- 56782V107
- ISIN
- US56782V1070
- EIN
- 27-4672745
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Jon R. Levine | President and CEO, Director | 28,043,271 |
| Ryan Crandall | Chief Commercial Officer | 1,128,197 |
| Timothy Shaw | Chief Operating Officer | 11,454,600 |
| Mario Pinho | Chief Financial Officer | 365,761 |
| Edward J. Gildea | Director | 1,172,516 |
| David R. Allen | Director | 743,452 |
| Eva M.D. Selhub | Director | 730,748 |
| Kathleen Tucker | Director | 350,000 |
Employees
Headcount reported in annual reports
“At December 31, 2025, we had a total of 923 employees, of which 808 were full-time.”
Corporate history
Events identified from SEC filings